Dynamics of cell cycle phase perturbations by trabectedin (ET-743) in nucleotide excision repair (NER)-deficient and NER-proficient cells, unravelled by a novel mathematical simulation approach

Cell Proliferation

Volumn 40, Issue 6, 2007, Pages 885-904

  Tavecchio, M ^a   Natoli, C ^a   Ubezio, P ^a   Erba, E ^a   D'Incalci, M ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRABECTEDIN;

ANIMAL CELL; ARTICLE; CELL CYCLE PHASE; CELL DAMAGE; CELL GROWTH; CELL POPULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; EXCISION REPAIR; FLOW CYTOMETRY; MATHEMATICAL MODEL; MOUSE; NONHUMAN;

ANIMALS; BROMODEOXYURIDINE; CELL COUNT; CELL CYCLE; CELL DEATH; CELL LINE; CELL PROLIFERATION; CHO CELLS; COLONY-FORMING UNITS ASSAY; COMPUTER SIMULATION; CRICETINAE; CRICETULUS; DIOXOLES; DNA; DNA REPAIR; FLOW CYTOMETRY; G1 PHASE; G2 PHASE; MODELS, BIOLOGICAL; S PHASE; TETRAHYDROISOQUINOLINES;

EID: 36248974108     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2007.00469.x     Document Type: Article

References (29)

1. Aitkin M, Anderson D, Francis B, Hinde J (1989) Statistical Modelling in GLIM. Oxford, UK : Clarendon Press.
2. Damia G, Silvestri S, Carrassa L, Filiberti L, Faircloth GT, Liberi G, Foiani M, D'Incalci M (2001) Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways. Int. J. Cancer 92, 583 588.
3. Erba E, Bergamaschi D, Bassano L, Damia G, Ronzoni S, Faircloth GT, D'Incalci M (2001) Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action. Eur. J. Cancer 37, 97 105.
4. TM (ET-743, trabectedin) are shared by its analog PM00128 which lacks the C ring. Oncol. Res. 14, 579 587.
5. Friedberg EC (2003) DNA damage and repair. Nature 421, 436 440.
6. Garcia-Carbonero R, Supko JG, Manola J, Seiden MV, Harmon D, Ryan DP, Quigley MT, Merriam P, Canniff J, Goss G, Matulonis U, Maki RG, Lopez T, Puchalski TA, Sancho MA, Gomez J, Guzman C, Jimeno J, Demetri GD (2004) Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy. J. Clin. Oncol. 22, 1480 1490.
7. Ghielmini M, Colli E, Erba E, Bergamaschi D, Pampallona S, Jimeno J, Faircloth G, Sessa C (1998) In vitro schedule-dependency of myelotoxicity and cytotoxicity of ecteinascidin 743 (ET-743). Ann. Oncol. 9, 989 993.
8. Guan Y, Sakai R, Rinehart KL, Wang AHJ (1993) Molecular and crystal structures of ecteinascidins: potent antitumor compounds from the Caribbean tunicate Ecteinascidia turbinata. J. Biomol. Struct. Dyn. 10, 793 818.
9. Hendriks HR, Fiebig HH, Giavazzi R, Langdon SP, Jimeno JM, Faircloth GT (1999) High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer. Ann. Oncol. 10, 1233 1240.
10. Herrero AB, Martin-Castellanos C, Marco E, Gago F, Moreno S (2006) Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin. Cancer Res. 66, 8155 8162.
11. Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411, 366 374.
12. Jimeno JM, Faircloth G, Cameron L, Meely K, Vega E, Gomez A, Fernandezsousa-Faro JM, Rinehart K (1996) Progress in the acquisition of new marine-derived anticancer compounds: development of ecteinascidin-743 (ET-743). Drugs Future 21, 1155 1165.
13. Li WW, Takahashi N, Jhanwar S, Cordon-Cardo C, Elisseyeff Y, Jimeno J, Faircloth G, Bertino JR (2001) Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent. Clin. Cancer Res. 7, 2908 2911.
14. Lupi M, Matera G, Branduardi D, D'Incalci M, Ubezio P (2004) Cytostatic and cytotoxic effects of topotecan decoded by a novel mathematical simulation approach. Cancer Res. 64, 2825 2832.
15. Lupi M, Cappella P, Matera G, Natoli C, Ubezio P (2006) Interpreting cell cycle effects of drugs: the case of melphalan. Cancer Chemother. Pharmacol. 57, 443 457.
16. Martinez EJ, Corey EJ, Owa T (2001) Antitumor activity- and gene expression-based profiling of ecteinascidin (Et) 743 and phthalascidin Part 650. Chem. Biol. 146, 1 10.
17. Minuzzo M, Marchini S, Broggini M, Faircloth GT, D'Incalci M, Mantovani R (2000) Interference of transcriptional activation by the anti-neoplastic drug ET-743. Proc. Natl. Acad. Sci. USA 97, 6780 6784.
18. Montalenti F, Sena G, Cappella P, Ubezio P (1998) Simulating cancer-cell kinetics after drug treatment: application to cisplatin on ovarian carcinoma. Phys. Rev. E 57, 5877 5887.
19. Pommier Y, Kohlhagen G, Bailly C, Waring M, Mazumder A, Kohn KW (1996) DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata. Biochemistry 35, 13303 13309.
20. Rinehart KL, Holt TG, Fregeau NL, Stroh JG, Keifer PA, Li LH, Martin DG (1990) Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. J. Org. Chem. 55, 4512 4515.
21. Sessa C, de Braud F, Perotti A, Bauer J, Curigliano G, Noberasco C, Zanaboni F, Gianni L, Marsoni S, Jimeno J, D'Incalci M, Dall'O E, Colombo N (2005) Trabectedin (ET-743) for women with ovarian carcinoma after treatment with platinum and taxanes fails. J. Clin. Oncol. 23, 1867 1874.
22. Takebayashi Y, Goldwasser F, Urasaki Y, Kohlhagen G, Pommier Y (2001a) Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression. Clin. Cancer Res. 7, 185 191.
23. Takebayashi Y, Pourquier P, Zimonjic DB, Nakayama K, Emmert S, Ueda T, Urasaki Y, Kanzaki A, Akiyama SI, Popescu N, Kraemer KH, Pommier Y (2001b) Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair. Nat. Med. 7, 961 966.
24. Ubezio P (1985) Microcomputer experience in analysis of flow cytometric DNA distributions. Comput. Programs Biomed. 19, 159 166.
25. Valerie K, Povirk LF (2003) Regulation and mechanisms of mammalian double-strand break repair. Oncogene 22, 5792 5812.
26. Valoti G, Nicoletti MI, Pellegrino A, Jimeno J, Hendriks H, D'Incalci M, Faircloth G, Giavazzi R (1998) Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts. Clin. Cancer Res. 4, 1977 1983.
27. Zelek L, Yovine A, Brain E, Turpin F, Taamma A, Riofrio M, Spielmann M, Jimeno J, Misset JL (2006) A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer. Br. J. Cancer 94, 1610 1614.
28. Zewail-Foote M, Hurley LH (1999) Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove. J. Med. Chem. 42, 2493 2497.
29. Zewail-Foote M, Li VS, Kohn H, Bearss D, Guzman M, Hurley LH (2001) The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent. Chem. Biol. 8, 1033 1049.